Journal article
The influence of physician recommendation on prostate-specific antigen screening
Urologic oncology, Vol.33(10), pp.424.e1-424.e7
10/01/2015
DOI: 10.1016/j.urolonc.2015.06.013
PMID: 26206103
Abstract
Prostate-specific antigen (PSA) screening is controversial, and little is known regarding a physician’s effect on a patient’s decision to undergo screening. This study’s objective was to evaluate the effect of a patient’s understanding of the risks and benefits of screening compared to the final recommendation of the provider on the patient’s decision to undergo PSA screening.
Using the 2012 Behavioral Risk Factor Surveillance System, men older than 55 years who did not have a history of prostate cancer/prostate “problem” and who reported a PSA test within the preceding year were considered to have undergone screening. The percentages of men informed and not informed of the risks and benefits of screening and the percentage men receiving recommendations for PSA screening from their provider were reported. Multivariable complex-sample logistic regression calculated the odds of undergoing screening.
In all, 75% of men were informed of screening benefits; however, 32% were informed of screening risks. After being informed of both, 56% of men opted for PSA screening if the provider recommended it, compared with only 21% when not recommended. Men receiving a recommendation to undergo PSA testing had higher odds of undergoing screening (odds ratio [OR] = 4.98, 95% CI: 4.53–5.48) compared with those who were only informed about screening benefits (OR = 2.40, 95% CI: 2.18–2.65) or risks (OR = 0.92, 95% CI: 0.86–0.98). Significant limitations include recall and nonresponse bias.
Patients’ decision to undergo or forgo PSA screening is heavily influenced by the recommendation of their physician; it is imperative that physicians are cognizant of their biases and facilitate a shared decision-making process.
•Men are 5x more likely to undergo PSA screening if their PCP recommends it•75% vs. 32% of men counseled regarding PSA screening benefits vs. risks•Physicians should be aware of personal bias and facilitate shared decision making
Details
- Title: Subtitle
- The influence of physician recommendation on prostate-specific antigen screening
- Creators
- Daniel Pucheril - Henry Ford Health SystemDeepansh Dalela - Henry Ford Health SystemJesse Sammon - Henry Ford Health SystemAkshay Sood - Henry Ford Health SystemMaxine Sun - Dana-Farber Cancer InstituteQuoc-Dien Trinh - Dana-Farber Cancer InstituteMani Menon - Henry Ford Health SystemFiras Abdollah - Henry Ford Health System
- Resource Type
- Journal article
- Publication Details
- Urologic oncology, Vol.33(10), pp.424.e1-424.e7
- DOI
- 10.1016/j.urolonc.2015.06.013
- PMID
- 26206103
- NLM abbreviation
- Urol Oncol
- ISSN
- 1078-1439
- eISSN
- 1873-2496
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 10/01/2015
- Academic Unit
- Urology
- Record Identifier
- 9984949177202771
Metrics
2 Record Views